Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 4;6(5):e011769.
doi: 10.1136/bmjopen-2016-011769.

Cognitive-Behavioural Analysis System of Psychotherapy (CBASP), a drug, or their combination: differential therapeutics for persistent depressive disorder: a study protocol of an individual participant data network meta-analysis

Toshi A Furukawa  1 , Elisabeth Schramm  2 , Erica S Weitz  3 , Georgia Salanti  4 , Orestis Efthimiou  4 , Johannes Michalak  5 , Norio Watanabe  1 , Andrea Cipriani  6 , Martin B Keller  7 , James H Kocsis  8 , Daniel N Klein  9 , Pim Cuijpers  3
Affiliations

Cognitive-Behavioural Analysis System of Psychotherapy (CBASP), a drug, or their combination: differential therapeutics for persistent depressive disorder: a study protocol of an individual participant data network meta-analysis

Toshi A Furukawa et al. BMJ Open. .

Abstract

Introduction: Despite important advances in psychological and pharmacological treatments of persistent depressive disorders in the past decades, their responses remain typically slow and poor, and differential responses among different modalities of treatments or their combinations are not well understood. Cognitive-Behavioural Analysis System of Psychotherapy (CBASP) is the only psychotherapy that has been specifically designed for chronic depression and has been examined in an increasing number of trials against medications, alone or in combination. When several treatment alternatives are available for a certain condition, network meta-analysis (NMA) provides a powerful tool to examine their relative efficacy by combining all direct and indirect comparisons. Individual participant data (IPD) meta-analysis enables exploration of impacts of individual characteristics that lead to a differentiated approach matching treatments to specific subgroups of patients.

Methods and analysis: We will search for all randomised controlled trials that compared CBASP, pharmacotherapy or their combination, in the treatment of patients with persistent depressive disorder, in Cochrane CENTRAL, PUBMED, SCOPUS and PsycINFO, supplemented by personal contacts. Individual participant data will be sought from the principal investigators of all the identified trials. Our primary outcomes are depression severity as measured on a continuous observer-rated scale for depression, and dropouts for any reason as a proxy measure of overall treatment acceptability. We will conduct a one-step IPD-NMA to compare CBASP, medications and their combinations, and also carry out a meta-regression to identify their prognostic factors and effect moderators. The model will be fitted in OpenBUGS, using vague priors for all location parameters. For the heterogeneity we will use a half-normal prior on the SD.

Ethics and dissemination: This study requires no ethical approval. We will publish the findings in a peer-reviewed journal. The study results will contribute to more finely differentiated therapeutics for patients suffering from this chronically disabling disorder.

Trial registration number: CRD42016035886.

Keywords: Differential therapeutics; Systematic review.

PubMed Disclaimer

References

    1. Murphy JA, Byrne GJ. Prevalence and correlates of the proposed DSM-5 diagnosis of chronic depressive disorder. J Affect Disord 2012;139:172–80. 10.1016/j.jad.2012.01.033 - DOI - PubMed
    1. Kessler RC, Berglund P, Demler O et al. . Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593–602. 10.1001/archpsyc.62.6.593 - DOI - PubMed
    1. McCullough JP Jr, Klein DN, Keller MB et al. . Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction. J Abnorm Psychol 2000;109:419–27. 10.1037/0021-843X.109.3.419 - DOI - PubMed
    1. McCullough JP Jr, Klein DN, Borian FE et al. . Group comparisons of DSM-IV subtypes of chronic depression: validity of the distinctions, part 2. J Abnorm Psychol 2003;112:614–22. 10.1037/0021-843X.112.4.614 - DOI - PubMed
    1. Angst J, Gamma A, Rössler W et al. . Long-term depression versus episodic major depression: results from the prospective Zurich study of a community sample. J Affect Disord 2009;115:112–21. 10.1016/j.jad.2008.09.023 - DOI - PubMed